NEOGENNeogen Chemicals Limited
Chemicals · Specialty Chemicals · NSE · as of 2026-10-26 (delayed ~30 min in market hours)
Neogen Chemicals Limited engages in the manufacture and sale of specialty chemicals in India. It offers organo bromine compounds, such as alkyl bromide compounds, dibromoalkane compounds, bromo chloro alkanes, bromine derivatives of organoacids, bromoacid ester compounds, aromatic bromine derivatives, cyclic bromine derivatives, and speciality bromo fluro derivatives; speciality chloro compounds comprising unsaturated bromine derivatives, bromo hydroxy derivatives, and other compounds; and organo lithium compounds, including n-butyl lithium, lithium hexamethyldisilazide, lithium tetrahydride borate, lithium diisopropylamide, lithium tri-(t-butoxy) aluminium hydride, hexyl lithium, methyl lithium, and phenyl lithium. The company also provides inorganic chemicals comprising inorganic bromine compounds and lithium salts; grignard reagents; advance intermediates; and chemistries, such as alkylation, amination, oxidation, dehalogenation, silylation, anhydrous HF and HBr reactions, suzuki coupling, hydrogenation, and biocatalysis. It serves pharmaceuticals, agrochemicals, engineering, electronics, polymers, water treatment, construction, aroma chemicals, flavors and fragrances, specialty polymers, vapor absorption chillers, emerging battery material applications, and other industries. The company also exports its products to 33 countries. Neogen Chemicals Limited was incorporated in 1989 and is based in Thane, India.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
None of the 16 pattern scanners currently detects a setup on NEOGEN — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.
The picture
- • Revenue growth: 34.0% YoY
- • Profit growth: 61.7% YoY
- • Promoter holding: 50.2%
- • Price vs SMA200: above
- • Golden cross setup: SMA50 above SMA200
- • 3-month vs NIFTY: +11.7% relative
Bull case
- • Revenue growth: 34.0% YoY
- • Profit growth: 61.7% YoY
- • Promoter holding: 50.2%
- • Price vs SMA200: above
Bear case
- • ROE: 3.5%
- • ROCE: 5.0%
- • RSI: 38
- • MACD: bearish
Key risks
- • Weak fundamentals — technical strength may not sustain
- • ROE: 3.5%
- • ROCE: 5.0%
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹124.58). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.